Evotec SE: Form 20-F for the period ended Dec 31, 2023
Filed with the SEC on Aug 14, 2024 and accepted by EDGAR at Aug 14, 2024, 06:01 ET.
Sections
Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. The main document on sec.gov.
Figures reported in this filing
Standardized line items from the XBRL in this filing, for the period ended 2023-12-31. Comparative periods it repeats are left out.
| Line item | Period | Value | XBRL concept |
|---|---|---|---|
| Revenue | 12 months2023-01-01 to 2023-12-31 | EUR 781.4m | ifrs-full:Revenue |
| Cost of revenue | 12 months2023-01-01 to 2023-12-31 | EUR 606.4m | ifrs-full:CostOfSales |
| Gross profit | 12 months2023-01-01 to 2023-12-31 | EUR 175.1m | ifrs-full:GrossProfit |
| Operating income | 12 months2023-01-01 to 2023-12-31 | −EUR 47.5m | ifrs-full:ProfitLossFromOperatingActivities |
| Income tax | 12 months2023-01-01 to 2023-12-31 | EUR 3.3m | ifrs-full:IncomeTaxExpenseContinuingOperations |
| Net income | 12 months2023-01-01 to 2023-12-31 | −EUR 83.9m | ifrs-full:ProfitLoss |
| Diluted EPS | 12 months2023-01-01 to 2023-12-31 | −EUR 0.47 | ifrs-full:DilutedEarningsLossPerShare |
| Basic EPS | 12 months2023-01-01 to 2023-12-31 | −EUR 0.47 | ifrs-full:BasicEarningsLossPerShare |
| Operating cash flow | 12 months2023-01-01 to 2023-12-31 | EUR 36.4m | ifrs-full:CashFlowsFromUsedInOperatingActivities |
| Capital expenditure | 12 months2023-01-01 to 2023-12-31 | EUR 213.3m | ifrs-full:PurchaseOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities |
| Cash and equivalents | At period end2023-12-31 | EUR 510.9m | ifrs-full:CashAndCashEquivalents |
| Current assets | At period end2023-12-31 | EUR 903.2m | ifrs-full:CurrentAssets |
| Total assets | At period end2023-12-31 | EUR 2.25bn | ifrs-full:Assets |
| Current liabilities | At period end2023-12-31 | EUR 464.6m | ifrs-full:CurrentLiabilities |
| Shareholders' equity | At period end2023-12-31 | EUR 1.12bn | ifrs-full:EquityAttributableToOwnersOfParent |
| Shares outstanding | At period end2023-12-31 | 177,185,736 shares | dei:EntityCommonStockSharesOutstanding |
Source: SEC EDGAR, the filing index for accession 0001104659-24-089121. Last ingested by Listed: Nov 5, 2026, 12:02 ET. Listed shows no prices and gives no investment advice.